These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


623 related items for PubMed ID: 9743367

  • 1. Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16).
    Hazenbos WL, Heijnen IA, Meyer D, Hofhuis FM, Renardel de Lavalette CR, Schmidt RE, Capel PJ, van de Winkel JG, Gessner JE, van den Berg TK, Verbeek JS.
    J Immunol; 1998 Sep 15; 161(6):3026-32. PubMed ID: 9743367
    [Abstract] [Full Text] [Related]

  • 2. Tyrosine-containing activation motif-dependent phagocytosis in mast cells.
    Daëron M, Malbec O, Bonnerot C, Latour S, Segal DM, Fridman WH.
    J Immunol; 1994 Jan 15; 152(2):783-92. PubMed ID: 8283051
    [Abstract] [Full Text] [Related]

  • 3. Factors influencing the endocytosis of immune complexes.
    van Es LA, Daha MR.
    Adv Nephrol Necker Hosp; 1984 Jan 15; 13():341-67. PubMed ID: 6236677
    [Abstract] [Full Text] [Related]

  • 4. Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice.
    Hazenbos WL, Gessner JE, Hofhuis FM, Kuipers H, Meyer D, Heijnen IA, Schmidt RE, Sandor M, Capel PJ, Daëron M, van de Winkel JG, Verbeek JS.
    Immunity; 1996 Aug 15; 5(2):181-8. PubMed ID: 8769481
    [Abstract] [Full Text] [Related]

  • 5. IgG-mediated enhancement of antibody responses is low in Fc receptor gamma chain-deficient mice and increased in Fc gamma RII-deficient mice.
    Wernersson S, Karlsson MC, Dahlström J, Mattsson R, Verbeek JS, Heyman B.
    J Immunol; 1999 Jul 15; 163(2):618-22. PubMed ID: 10395649
    [Abstract] [Full Text] [Related]

  • 6. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.
    Ann Rheum Dis; 2008 Feb 15; 67(2):154-61. PubMed ID: 17557887
    [Abstract] [Full Text] [Related]

  • 7. Proteolysis induces increased binding affinity of the monocyte type II FcR for human IgG.
    van de Winkel JG, van Ommen R, Huizinga TW, de Raad MA, Tuijnman WB, Groenen PJ, Capel PJ, Koene RA, Tax WJ.
    J Immunol; 1989 Jul 15; 143(2):571-8. PubMed ID: 2525588
    [Abstract] [Full Text] [Related]

  • 8. Fc gamma receptor-mediated activation of phospholipase D regulates macrophage phagocytosis of IgG-opsonized particles.
    Kusner DJ, Hall CF, Jackson S.
    J Immunol; 1999 Feb 15; 162(4):2266-74. PubMed ID: 9973503
    [Abstract] [Full Text] [Related]

  • 9. Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes.
    Bredius RG, Fijen CA, De Haas M, Kuijper EJ, Weening RS, Van de Winkel JG, Out TA.
    Immunology; 1994 Dec 15; 83(4):624-30. PubMed ID: 7875742
    [Abstract] [Full Text] [Related]

  • 10. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.
    Rotman HL, Daly TM, Clynes R, Long CA.
    J Immunol; 1998 Aug 15; 161(4):1908-12. PubMed ID: 9712060
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fc gamma RIII (CD16) on human macrophages is a functional product of the Fc gamma RIII-2 gene.
    Perussia B, Ravetch JV.
    Eur J Immunol; 1991 Feb 15; 21(2):425-9. PubMed ID: 1825635
    [Abstract] [Full Text] [Related]

  • 13. Coordinate expression of activating Fc gamma receptors I and III and inhibiting Fc gamma receptor type II in the determination of joint inflammation and cartilage destruction during immune complex-mediated arthritis.
    Nabbe KC, Blom AB, Holthuysen AE, Boross P, Roth J, Verbeek S, van Lent PL, van den Berg WB.
    Arthritis Rheum; 2003 Jan 15; 48(1):255-65. PubMed ID: 12528127
    [Abstract] [Full Text] [Related]

  • 14. Defective Fc gamma RII gene expression in macrophages of NOD mice: genetic linkage with up-regulation of IgG1 and IgG2b in serum.
    Luan JJ, Monteiro RC, Sautès C, Fluteau G, Eloy L, Fridman WH, Bach JF, Garchon HJ.
    J Immunol; 1996 Nov 15; 157(10):4707-16. PubMed ID: 8906852
    [Abstract] [Full Text] [Related]

  • 15. IgG immune complex-binding in macrophages from arthritis-susceptible and arthritis-resistant mice following collagen type II immunization.
    Thorvaldson L, Fuchs D, Magnusson S, Kleinau S.
    Scand J Immunol; 2006 May 15; 63(5):347-54. PubMed ID: 16640658
    [Abstract] [Full Text] [Related]

  • 16. Fc receptors on cultured myeloma and hybridoma cells.
    Teillaud JL, Diamond B, Pollock RR, Fajtova V, Scharff MD.
    J Immunol; 1985 Mar 15; 134(3):1774-9. PubMed ID: 3155773
    [Abstract] [Full Text] [Related]

  • 17. Membrane and soluble Fc gamma RII/III modulate the antigen-presenting capacity of murine dendritic epidermal Langerhans cells for IgG-complexed antigens.
    Esposito-Farese ME, Sautès C, de la Salle H, Latour S, Bieber T, de la Salle C, Ohlmann P, Fridman WH, Cazenave JP, Teillaud JL.
    J Immunol; 1995 Aug 15; 155(4):1725-36. PubMed ID: 7636231
    [Abstract] [Full Text] [Related]

  • 18. Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages.
    Arikawa T, Watanabe K, Seki M, Matsukawa A, Oomizu S, Sakata KM, Sakata A, Ueno M, Saita N, Niki T, Yamauchi A, Hirashima M.
    Clin Immunol; 2009 Dec 15; 133(3):382-92. PubMed ID: 19800850
    [Abstract] [Full Text] [Related]

  • 19. Neutrophil Fc gamma and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexes.
    Voice JK, Lachmann PJ.
    Eur J Immunol; 1997 Oct 15; 27(10):2514-23. PubMed ID: 9368604
    [Abstract] [Full Text] [Related]

  • 20. Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells.
    Rüegg SJ, Jungi TW.
    Immunology; 1988 Mar 15; 63(3):513-20. PubMed ID: 2965100
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.